CagriSema
Drug timelines are a Plus or Pro feature.
28 regulatory and trial events tracked for CagriSema, covering 2025-05-11 to 2026-07-17. Get the full timeline:
Most recent: Clinical Trial Update: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both [Phase 3]